Medical Device Leader Series - Top Companion Diagnostic Companies 2013-2023
The future of companion diagnostics appears promising and has significant potential for growth owing to the increasing demand for safer and more effective therapies. Furthermore, the global companion diagnostics market will benefit from a positive reimbursement outlook in key regional markets, primarily due to the cost-effective nature of the tests.
Leading companion diagnostic companies profiled in the report include: Abbott Laboratories, Inc., Myriad Genetics, Genomic Health, Johnson and Johnson, LabCorp, Life Technologies, QIAGEN, Roche, Dako (Agilent Technologies, bioMerieux, Siemens, and MDx Health.
Highlights from the report include: the growing number of companies entering the companion diagnostics market; Roche as a one stop shop for companion diagnostics; commercial market drivers; and emerging technologies that will help drive the companion diagnostics market forward.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/kt253510-medical-device-leader-series-top-needle-free.html
The Complete Guide to Companion Diagnostics: Market Environment Products and Companies
While personalized medicine is not new it is only relatively recently that diagnostics companies and pharma have converged to explore and exploit its potential benefits. By using companion diagnostics, companies can identify those patients who will benefit most from, or suffer f
|SOURCE Global Information, Inc.|
Copyright©2012 PR Newswire.
All rights reserved